#ClinicalReview
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-rev... or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
September 22, 2026 at 6:02 PM
ImmunoSky #Immunology #Clinicalreview summarized recent advances in #Bcell targeted therapies in #autoimmunedisease of the #centralnervoussystem including #multiplesclerosis , #neuromyelitisopticaspectrumdisorder and MOG antibodies associated diseases (MOGAD)…

www.frontiersin.org/articles/10....
Editorial: Next generation B cell targeting therapies in autoimmune diseases
Editorial: Next generation B cell targeting therapies in autoimmune diseases
www.frontiersin.org
November 10, 2023 at 3:17 PM
September 15, 2024 at 11:59 AM
MedSky🧪#IDSky #viralimmunology The infographic that tell 1000 words & not an organ to spare by #COVID19 collateral damages #MaskUp😷 & #GetBoosted This comprehensive #clinicalreview of #COVID19 from host extracellular to systemic effects of #SARSCoV2 infection!
Part 2
www.nature.com/articles/s41...
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SA...
European Journal of Human Genetics - A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
www.nature.com
November 11, 2023 at 2:02 PM
#MedSky🧪#IDSky #Publichealth This #Clinicalreview the current state of knowledge regarding the #biology & #pathophysiology of #longCOVID focusing on how the proposed mechanisms explain the #physiology of the syndrome & the implementation of a broad #experimentalmedicine

www.cell.com/cell/fulltex...
Mechanisms of long COVID and the path toward therapeutics
Known under competing terms and definitions such as post-COVID-19 condition, post-COVID-19 conditions, post-acute sequelae of SARS-CoV-2 (PASC), post-COVID-19 syndrome, post-COVID-19, or long COVID, t...
www.cell.com
October 3, 2024 at 5:05 PM
#MedSky🧪#IDSky #Immunopharmacology #publichealth #Clinicalreview Summarize the major #Drugsdiscovery approaches, preclinical #antiviral evaluation models, representative virus-targeting , host-targeting therapeutic options
June 4, 2024 at 11:42 AM
In this #ClinicalReview define CVAD & its major forms that are encountered in LC describe possible CVAD aetiologies , discuss how CVAD, as a componen of LC can be diagnosed & managed. Outline directions for future research to discover more efficient ways to cope w this prevalent & long-lasting dx.
January 3, 2024 at 6:44 AM
#MedSky🧪#IDSky #ImmunoOncology in this #Clinicalreview present the summarised & overview of the various biological alterations induced by #SARSCoV2 infection and its proteins with respect to cancer hallmarks

biosignaling.biomedcentral.com/articles/10....
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and Signaling
The 2019 outbreak of SARS-CoV-2 has caused a major worldwide health crisis with high rates of morbidity and death. Interestingly, it has also been linked to cancer, which begs the issue of whether it ...
biosignaling.biomedcentral.com
September 27, 2024 at 12:54 PM
🆕🔥Central & peripheral #Neuromodulators in #FD & #Gastroparesis: Symptom-Based #ClinicalReview‼️
🎯A pragmatic, symptom-oriented & mechanism-based approach facilitate individualized treatment selection & optimize clinical outcomes
👉 onlinelibrary.wiley.com/doi/10.1111/...
#ANMS #ESNM
March 4, 2026 at 2:41 PM
Featured today by @MSKLibrary: Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety
#Ruxolitinib #PolycythemiaVera #ClinicalReview #hematology
@MDmasarova @RaajitRampal @doctorpemm

dx.doi.org/10.1002/cncr...
Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety
This study reviews the safety and efficacy profile of the oral JAK1/2 inhibitor ruxolitinib from the decade since its 2014 Food and Drug Administration approval for patients with polycythemia vera wh....
dx.doi.org
January 7, 2025 at 4:16 PM
#Medsky🧪#IDsky #immunosky #Publichealth #clinicalreview Interesting study .Does #SARSCoV2 Possess “Allergen-Like” Epitopes?

www.preprints.org/manuscript/2...
March 9, 2025 at 3:19 PM
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-reviewers/ or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
September 15, 2026 at 12:44 PM
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-rev... or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
September 8, 2026 at 6:40 PM
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-rev... or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
September 4, 2026 at 4:02 PM
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-reviewers/ or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
August 25, 2026 at 12:15 PM
Calling all board-certified physicians – we need you! 🫵

Learn more by visiting ipro.org/clinical-reviewers/ or by calling (888) 404-6285.

#ClinicalReview #PatientCare #Physicians
August 21, 2026 at 4:02 PM
We're looking for board-certified physicians with at least five years of active clinical experience who currently work at least 20 hours per month on direct patient care.🏥

Become a clinical reviewer today! Learn more by visiting ipro.org/clinical-rev... or calling 888-404-6285.

#ClinicalReview
August 13, 2026 at 2:01 PM
We're looking for board-certified physicians with at least 5 years of active clinical experience who currently work at least 20 hours per month on direct patient care. 🏥

Learn more by visiting ipro.org/clinical-rev... or calling 888-404-6285.

#Veterans #Healthcare #ClinicalReview
August 10, 2026 at 1:21 PM
We're looking for board-certified physicians with at least 5 years of active clinical experience who currently work at least 20 hours per month on direct patient care. 🏥

Learn more by visiting ipro.org/clinical-rev... or calling 888-404-6285.

#Veterans #Healthcare #ClinicalReview
August 4, 2026 at 3:06 PM
#MedSky🧪#Neuropharmacology #psychiatricdrugs #Clinicalreview on medicines containing #finasteride & #dutasteride following concerns regarding suicidal thoughts & behaviours. @EMA_News

www.ema.europa.eu/en/news/meet...
October 4, 2024 at 7:58 PM